The central pathogenic event of prion disease is the conformational conversion of a host protein, PrP C , into a pathogenic isoform, PrP Sc . We previously showed that the protein misfolding cyclic amplification (PMCA) technique can be used to form infectious prion molecules de novo from purified native PrP C molecules in an autocatalytic process requiring accessory polyanions (1). Here, we investigated the molecular mechanism by which polyanionic molecules facilitate infectious prion formation in vitro. In a PMCA reaction lacking PrP Sc template seed, synthetic poly(A) RNA molecules induce hamster (Ha)PrP C to adopt a protease-sensitive, detergent-insoluble conformation reactive against antibodies specific for PrP Sc . During PMCA, labeled nucleic acids form nuclease-resistant complexes with HaPrP molecules. Strikingly, purified HaPrP C molecules subjected to PMCA selectively incorporate an ~1-2.5 kb subset of [ 32 P]-poly(A) RNA molecules from a heterogeneous mixture ranging in size from ~0.1 to > 6 kb. Neuropathological analysis of scrapie-infected hamsters using the fluorescent dye acridine orange revealed that RNA molecules co-localize with large extracellular HaPrP aggregates. These findings suggest that polyanionic molecules such as RNA may become selectively incorporated into stable complexes with PrP molecules during the formation of native hamster prions.
Introduction
Prion diseases are fatal neurodegenerative disorders that occur in inherited, sporadic, and infectious forms (2) . In both the sporadic and infectious forms of prion disease, the host-encoded prion protein (PrP C ) appears to undergo conformational change into a pathogenic isoform (PrP Sc ), and it has been proposed that prions are unorthodox infectious agents composed of only PrP Sc molecules (3) . Currently, the molecular mechanism by which native PrP C molecules are converted into PrP Sc molecules remains unknown.
2
A variety of genetic and biochemical studies have suggested that cofactors other than PrP C molecules may be required for prion formation (4) (5) (6) (7) (8) (9) (10) (11) (12) ; reviewed in (13) . Several classes of negatively-charged macromolecules have been shown to bind to and/or influence PrP conformation in vitro, including: nucleic acids (14) (15) (16) (17) (18) (19) (20) (21) (22) (23) , glycosaminoglycans (24) (25) (26) (27) (28) , phospholipidrich membranes (29) (30) (31) (32) , and chaperone proteins (33) . However, it is not clear whether similar events occur during the formation of native prions because previously there has been no experimental system available that could produce wild type infectious prions from defined components. Our laboratory has recently used the protein misfolding cyclic amplification (PMCA) technique (34) (35) (36) (37) to produce native hamster prions in vitro from purified hamster (Ha) PrP C molecules (1) . Interestingly, addition of an accessory polyanion (such as synthetic poly(A) RNA) facilitated the formation of infectious prions in this chemically defined system, as confirmed by bioassays in wild type hamsters. Furthermore, using this polyanion-dependent system, we also demonstrated, for the first time, that wild type prion infectivity could be generated de novo (i.e. without infectious seed in a rigorously prion-free environment) (1) . In this manuscript, we characterize the molecular interactions between polyanions and purified HaPrP C substrate during PMCA-induced formation of hamster prions.
Experimental Procedures Reagents
Synthetic poly(A) catalog # P9403 (0.2-6 kb by agarose gel electrophoresis) was purchased from Sigma-Aldrich (St. Louis, MO). Synthetic 100-mer oligo(dA), (dT), (dC), (dG), 100-mer fluorescein-labeled oligo(dT) and oligo(dA), and 100-mer biotin-labeled oligo(dT) were purchased from Operon (Huntsville, AL). Branched oligo(dT) constructs were purchased from Fidelity Systems (Gaithersburg, MD). EasyTides Adenosine 5' Triphosphate, [!- 32 P] catalog # BLU503H250UC was obtained from Perkin Elmer (Boston, MA). Stock solutions of synthetic polynucleotides were dissolved in 1x TE pH 8.0, and concentrations were confirmed by OD 260 prior to use. Dynabeads ® M-450 Rat antiMouse IgM catalog # 110-39D and ProLong ® Antifade catalog # P7481 were obtained from Invitrogen (Carlsbad, CA). The anti-PrP 27-33 mAb was obtained from Dr. Peter Morganelli (VA Hospital, White River Junction, VT). The 15B3 mAb, 15B3 coating buffer, immunoprecipitation buffer, and IP wash buffer were obtained from Prionics AG (Schleiren-Zurich, Switzerland). The 89-112 and D13 mAbs were kindly provided by Dr. Anthony Williamson (La Jolla, CA). Benzonase catalog # 70664-3 was obtained from Novagen (Madison, WI). The bacterially expressed recombinant mouse PrP was kindly provided by Roland Riek (La Jolla, CA). Anti-actin antibody catalog # A5060, polyadenylic acid-Sepharose catalog # P2765, heparin-agarose catalog # H3025, poly-L glutamate catalog # P4886, heparan sulfate catalog # H7640, polynucleotide phosphorylase catalog # P2869, acetylated bovine serum albumin catalog # B8894, hexokinase catalog # H4502, SP-agarose catalog # S1799, deoxycholic acid, sodium salt catalog # D6750, MOPS catalog # M5789, MES catalog # M5287, and imidazole catalog # I-5513 were purchased from Sigma-Aldrich. CNBr-activated Sepharose 4 Fast Flow catalog # 17-0981-01 was purchased from Amersham. RNase-free water and stock solutions of NaCl, EDTA, TE pH 8.0, and Tris pH 8.0 were purchased from Ambion (Austin, TX). Other chemical reagents, including protein A-agarose catalog # PI20333, were purchased at the highest grade available from Fisher Scientific (Pittsburgh, PA). All phosphate buffered saline (PBS) was without calcium or magnesium, and purchased from Mediatech, Inc. (Herndon, VA). Teflon printed slides catalog # 63415-15 were obtained from Electron Microscopy 0.25 M NaCl, 1% Triton X-100. The column was eluted with 8 ml 20 mM MOPS pH 7.0, 0.5 M NaCl, 1% Triton X-100 and applied to Zeba desalting spin columns preequilibrated with 20 mM MOPS pH 7.5, 0.15 M NaCl, 0.5% Triton X-100 to reduce the salt concentration of the final product. The typical yield from a preparation using 6 hamster brains is ~16 µg PrP C (~2 µg/ml), based on comparison with known concentrations of E. coli-expressed recombinant PrP, using semi-quantitative Western blots and silver stain gels.
Protein misfolding cyclic amplification (PMCA)
PMCA and serial dilution/propagation experiments were performed as described by Castilla et al., using purified substrates instead of brain homogenates. To avoid cross-contamination, all work was carried out in laminar flow biosafety cabinets using disposable surfaces and aerosol barrier tips. Typically, we prepared a cocktail containing 200 µl of PrP C substrate diluted in 20 mM MOPS pH 7.5, 0.15 M NaCl, 0.5% Triton X-100 (note that the appropriate dilution of PrP C substrate is empirically determined for each individual preparation using seeded, serial PrP Sc propagation assays; the final concentration of PrP C in the cocktail is typically between 250-500 ng/ml), 40 µl imidazole diluted in 20 mM MOPS, 0.15 M NaCl, 0.5% Triton, pH 7.0, 4 µl 0.5M EDTA, pH 8.0, and 116 µl TE buffer. From this cocktail, multiple 90 µl aliquots are dispensed into 0.5 ml thin walled PCR tubes. Where indicated, the TE buffer contained a polyanionic compound such as poly(A) RNA or synthetic oligonucleotides at a concentration of 68.96 µg/ml (to produce a final concentration of 20 µg/ml in the reaction) except for polyglutamate, heparan sulfate, oligo(dT) construct # 1, oligo(dT) construct # 2, and oligo(dT) construct # 3, which were used at final concentrations of 2 µg/ml, 50 µg/ml, 800 nM, 80 nM, and 80 nM, respectively. Aliquots were then frozen at -70 o C until use in PMCA reactions. Serial propagation reactions were initiated on day zero by the addition of 10 µl PrP Sc or 27-30PrP (or 10 µl of PrP C dilution buffer (20 mM MOPS pH 7.5, 0.15 M NaCl, 0.5% Triton X-100) for unseeded reactions) to both day 0 and day 1 tubes. Day 0 samples were immediately refrozen without sonication, and day 1 samples were subjected to PMCA for 24 h using a Misonix 3000-MPD programmable sonicator equipped with a microplate horn containing 350 ml water, set for 30 sec bursts every 30 min at output < 6.0. The appropriate output setting is determined empirically for each individual horn, and changes with usage. Temperature was maintained by circulating heated water through a section of aluminum coil to heat the air inside the acoustic chamber (Misonix, Farmingdale, NY), and the microplate horn was covered with a sheet of plastic film to minimize evaporation. Before each burst, the bath temperature measured 41 o C, and after each burst the temperature measured 42 o C. Samples were mounted into a custom-made Plexiglas holder with lid designed to keep the bottom of the PCR tubes ~ 3 mm from the horn surface and the tubes tightly closed. Samples were generally mounted no further than 4 cm from the center of the circular horn. With appropriate sonicator settings, the temperature inside a thin walled PCR tube filled with 250 µl water subjected to a single 30 sec pulse typically rose 1-3 o C (measured by thermistor readings). Immediately following the last sonication cycle of the first 24 hour round, the day 1 PMCA product was removed from the sonicator and centrifuged for 5 sec. Pipetting up and down several times resuspended the sample, and 10 µl was used to seed the thawed day 2 aliquot containing a fresh substrate mixture. The remainder of the day 1 sample was stored at -70 o C until analysis, and the day 2 sample was subjected to PMCA for 24 h in the second round of propagation. This process was repeated for multiple propagation rounds, up to 4 days.
PrP

Sc detection assays
All protease digested (+PK) samples were incubated with 50 µg/ml Proteinase K (Roche) for 1 h at 37 o C. An equal volume of 2x SDS sample buffer was then added and samples were boiled for 10 min at 95 o C. SDS-PAGE was performed on 1.5-mm 12% polyacrylamide gels with an acrylamide:bisacrylamide ratio of 29:1 (BioRad). Following electrophoresis, the proteins were transferred to a methanolcharged, buffer equilibrated polyvinylide difluoride (PVDF) membrane (Millipore) using a Trans-blot SD Semi-Dry Transfer Cell (Bio-Rad) set at 2 mA/cm 2 for 30 min. Slot blotting was performed by mixing 50 µl sample in SDS loading buffer with 100 µl of 100% ethanol, and then applying the mixed samples to an ethanol-charged, buffer equilibrated PVDF membrane sandwiched in a Schleisher and Schuell (Keene, NH) slot cassette.
To visualize PrP signals, Western and slot blot membranes were first treated with 3 M GdnSCN (Roche) at room temperature for 30 min. Then, membranes were rinsed with TBST (10 mM Tris pH 7.2, 150 mM NaCl, 0.1% Tween-20) and blocked for 1 h in Hood (Chelsea, MA) skim milk buffered with TBST. The blocked membrane was incubated overnight at 4 o C with 3F4 or 6D11 mAbs (Signet) diluted 1:5000 or 1:10,000, respectively, in TBST. Following this incubation, the membrane was washed 3 x 10 min in TBST, and incubated for 1 h at 4 o C with horseradish peroxidase-labeled anti-mouse IgG secondary antibody conjugate (GE Healthcare) diluted 1:5000 in TBST. The membrane was washed again 4 x 10 min with TBST. The blot was developed using West Pico or West Femto (Pierce) chemiluminescence substrate, sealed in plastic covers, and either exposed to Fujifilm (Tokyo, Japan) Super RX film or captured digitally using a Fuji (Fujifilm) LAS-3000 chemiluminescence documentation system. Exposed films were developed automatically in a Kodak M35A X-Omat film processor and digital images were captured using Image Reader version 2.0 and analyzed with Image Gauge version 4.22 software (Fujifilm, Tokyo, Japan). Relative molecular masses were based on migration of pre-stained standards from either Fermentas (Hanover, MD) or BioRad.
Immobilized
polyanion-PrP binding assays Crude hamster and mouse brain homogenates were prepared using a Teflon/glass Potter homogenizer. Brains were homogenized in cold PBS plus Complete™ protease inhibitor cocktail to a final brain concentration of 10% (w/v). Crude homogenates were centrifuged for 30 s at 200 x g and the post-nuclear supernatants were diluted in PBS plus 1% noctyl !-D-glycopyranoside (NOG), 5mM EDTA to a 1% final brain concentration. Supernatants were solubilized by incubating at 4°C for 1 hr and then centrifuged for 30 min at 20,800 x g at 4°C. 300 µl of solubilized supernatants were incubated with 50 µl of packed polyadenylic acidSepharose, heparin-agarose, or polyglutamate-Sepharose (coupled to CNBractivated Sepharose according to manufacturer's instructions) overnight at 4°C with tilt rotation. Following incubation, the samples were subjected to brief centrifugation and the sample supernatants were removed. The Sepharose/agarose pellets were washed with PBS plus 1% NOG, 5mM EDTA. Pellet-associated proteins were eluted by boiling the pellet with 50 µl of SDS loading buffer. Samples were subjected to SDS-PAGE and Western blot detection with anti-PrP mAb 27-33. Subsequently, each blot was stripped in 3M guanidine isothiocyanate 20mM Tris, pH 8.0 for 1 hr at room temperature and re-probed with anti-actin antibody.
PrP
C solubility assay Seeded and unseeded 100 µl PMCA reactions were performed in duplicate for each condition. Prior addition to each sample, the PrP C substrate was subjected to 100,000 x g centrifugation for 45 min at 4°C and the supernatant fraction was then used as the source of PrP C for each sample. After one round of PMCA, 1 ml PBS, 0.5% Triton X-100 was added to all samples which were then subjected to 100,000 x g centrifugation for 1 hr at 4°C. The sample supernatants were removed, the pellets were washed with 1 ml PBS, 0.5% Triton X-100 and the centrifugation step was repeated. All but 100 µl of the sample supernatants were removed by aspiration, and the pellets were resuspended by vortexing. An equal volume of 2x SDS loading buffer was added and each sample was boiled for 10 minutes at 95°C. Samples containing the input amounts of PrP C and PrP Sc added to the experimental samples were prepared at the same time, and all samples were analyzed together by Western blot with 3F4 mAb.
89-112 mAb PrP immunoprecipitation
100 µl PMCA reactions were carried out in duplicate for each condition. Seeded reactions contained PrP Sc template generated in a serial PMCA propagation reaction stimulated with synthetic poly(A) RNA. After overnight PMCA, 400 µl of IP buffer (TBS, 3% Tween-20, 3% NP-40) was added to each sample. 1.5 µg of 89-112 mAb was added to each sample for a final concentration of 3 µg/ml and the samples were incubated for 2 hr at room temperature with slow tilt rotation. 60 µl of a 50% slurry of Immunopure Protein A Plus (Pierce) was added to each sample and allowed to incubate for 40 min at room temperature with slow tilt rotation. Each sample was then centrifuged for 30 sec and the supernatant was removed by aspiration. 750 µl of wash buffer (TBST, 2% Tween-20, 2% NP-40) was added to each sample that was then mixed briefly by vortexing. The samples were centrifuged again for 30 sec and the wash buffer was removed by aspiration. Each sample was washed three more times in the same manner followed by a final wash with PBS. After aspiration of the PBS, 50 µl of 1x SDS loading buffer was added and each sample was boiled for 10 min at 95°C. All samples were analyzed together by Western blot with 3F4 mAb.
15B3 mAb PrP immunoprecipitation
Rat anti-mouse IgM Dynabeads ® were coated with 15B3 mAb at a concentration of 2 µg of antibody per 100 µl of beads. Beads were incubated with 15B3 in coating buffer for 2 hours at room temperature with slow tilt rotation. 15B3-coated beads were washed 3 times with coating buffer and then resuspended in a volume of coating buffer equivalent to the starting volume of beads. A Dynal MPC ™ -S Magnetic Particle Concentrator (Invitrogen) was used for all steps involved in 15B3 bead preparation and PrP immunoprecipitation.
For PrP immunoprecipitation, 100 µl PMCA reactions were carried out for each condition. Seeded samples contained PrP Sc template generated in a serial PMCA propagation reaction stimulated with synthetic poly(A) RNA. Each sample was combined with 400 µl of IP buffer and 15 µl of 15B3-coated beads. Samples were immunoprecipitated for 2 hr at room temperature with slow tilt rotation. The beads in each sample were washed three times with 1 ml of wash buffer. 30 µl of 2x SDS loading buffer was added to the beads in each sample which were then boiled for 5 min at 95°C. All samples were analyzed together by Western blot with 6D11 mAb.
Fluorescence microscopy analysis of purified PrP and fluorescein-oligo(dT) 100 For each sample, a seeded or unseeded 200 µl PMCA reaction was carried out. The polyanion added to the reactions was a synthetic oligo(dT) 100 or oligo(dA) 100 labeled with a fluorescein group at the 5' end of the oligo. The stock oligo was prepared in 1X TE, pH 8.0 and added to each reaction at a final concentration of 20 µg/ml. After one round of PMCA, each sample was combined with 800 µl of PBS and subjected to 100,000 x g centrifugation for 45 min at 4°C. All but approximately 100 µl of the sample supernatants were removed. At this point, MgCl 2 was added to a final concentration of 2mM along with 50 U of benzonase to those samples undergoing nuclease digestion. Benzonase-treated samples were then incubated for 30 min at 37°C with shaking at 300 rpm followed by addition of EDTA to a final concentration of 15 mM in order to inactivate the benzonase. Following the first centrifugation step, and the incubation step for benzonase treated samples, all samples were resuspended in PBS up to a final volume of 1 ml and subjected to 100,000 x g centrifugation for 45 min at 4°C. All but approximately 150 µl of the sample supernatants were removed. Samples treated with benzonase were subjected to an additional centrifugation and wash step. The sample pellets were then resuspended by vortexing and applied to 15 mm, singlewell, Teflon printed slides that were precoated with gelatin subbing solution. In order to prepare gelatin subbing solution, 6 g of 300 bloom gelatin was dissolved at 58°C in 500 ml of sterile distilled water. 0.2 g of chromium potassium sulfate was added to the solution after the gelatin dissolved. Gelatin subbing solution cooled to 50°C was applied to the slides in a volume large enough to cover the entire well and then allowed to dry for at least 2 hr at room temperature. Samples were incubated on the slides overnight in a humidified chamber at 4°C. The following day, the samples were fixed to the slide by addition of 150 µl of PBS, 8% formaldehyde. The samples were allowed to incubate at room temperature for 15 min and then removed by aspiration. Each slide well was washed one time with 150 µl of PBS. 150 µl of mAb D13 diluted 1:250 in PBS + 4% BSA was applied to each slide well and allowed to incubate overnight at 4°C or for 2 hr at room temperature in a humidified chamber. After primary antibody incubation, the slide well was washed three times with 150 µl of PBS + 4% BSA and allowed to incubated for 15 min at room temperature during each wash. 150 µl of secondary antibody, sheep antimouse conjugated with Alexa Fluor 568 (Invitrogen), diluted 1:250 in PBS + 4% BSA, was applied to each slide and allowed to incubate for 2 hr in the dark at room temperature in a humidified chamber. The slide well was then washed three times with 150 µl of PBS + 4% BSA and allowed to incubated for 15 min at room temperature during each wash. 15 µl of ProLong ® Antifade solution was added to each sample and #1.5, 18 mm square glass coverslips (Corning) were mounted on each slide and allowed to dry overnight in the dark in a desiccating chamber. We also prepared and analyzed a control slide coated with only reaction buffer and then stained with D13 mAb and Alexa Fluor 568 secondary antibody in order to rule out non-specific binding of either antibody to the slide. A slide coated with only fluorescein-labeled oligo(dT) 100 in reaction buffer was prepared to rule out non-specific binding of the fluorescein-labeled oligo(dT) 100 to the slide. Finally, a slide coated with PrP C in reaction buffer that did not contain fluoresceinlabeled oligo(dT) 100 was prepared to rule out auto-fluorescence of PrP C in the fluorescein excitation wavelength. Samples were analyzed by fluorescence microscopy using a Leica Confocal Model TES SP confocal scanning microscope (Leica Microsystems, Heidelberg GmbH). All images were captured digitally using a 63x, 1.32 aperture, oil-emersion objective lens, and Leica confocal system software, version 2.61. Image resolutions are 1024 x 1024 and are averages of 3 consecutive scans. Alexa Fluor 568 is displayed as magenta to be redgreen colorblind compatible. Images were processed (cropped, re-sized) using Photoshop software.
Enzymatic synthesis of [ 32 P]-Poly(A) RNA:
Radiolabeled poly(A) RNA was synthesized in a 100 µl reaction containing 100 mM Tris HCL, pH 9.0; 0.4 mM EDTA, pH 7.0; 5 mM MgCl 2 , 6 mM ATP, 70 mM glucose, 0.1 mg/ml acetylated bovine serum albumin, 2.5U/ml polynucleotide phosphorylase, 20U/ml hexokinase, and 2 mCi/ml of 3000Ci/mmol adenosine 5' triphosphate, [!- 32 P] . All components of the reaction, except polynucleotide phosphorylase, hexokinase, and [!-
32 P] ATP, were combined and prewarmed to 37°C. The enzymes and [!- 32 P] ATP were then added and the reaction mixture was incubated at 37°C for 45 min. Following incubation, the synthesized poly(A) RNA was purified using an RNeasy kit (Qiagen, Valencia, CA) following the manufacturer's instructions. The concentration of the purified poly(A) RNA was determined by measuring OD 260 .
Nuclease protection assay
For each condition 300 µl PMCA reactions were prepared on ice. Samples without PrP C contained PrP C dilution buffer (20 mM MOPS pH 7.5, 0.15 M NaCl, 0.5% Triton X-100) in the place of PrP C . [ 32 P] poly(A) RNA diluted into 1x TE, pH 8.0 was added to each sample for a final concentration of 20 µg/ml. Samples not subjected to PMCA were frozen at -70°C. The remaining samples were subjected to PMCA for 24 h. After 24 h the samples subjected to PMCA were frozen at -70°C for 30 min and then all samples were thawed on ice. 700 µl of PBS, 0.5% Triton X-100 was added to each sample which was then mixed briefly by vortex and subjected to 100,000 x g centrifugation for 45 min at 4°C. All but approximately 50 µl of the sample supernatants were removed. The sample pellets were washed by addition of 950 µl of PBS, 0.5% Triton X-100, briefly mixed by vortex, followed by 100,000 x g centrifugation for 45 min at 4°C. All but approximately 50 µl of the sample supernatants were removed. 100 µl of benzonase digestion buffer (50 mM Tris HCL, pH 9.0, 20 mM NaCl, 2 mM MgCl 2 ) was added to each sample and the pellets were resuspended by pipetting. 2 µl of 25 U/µl benzonase was added to nuclease treated samples. All samples were then incubated at 37 °C for 45 min with 300 rpm shaking (Eppendorf Thermomixer, Fisher Scientific). 50 µl of 100 mM EDTA, pH 8.0 and 900 µl PBS, 0.5% Triton X-100 were added to all samples. Each sample was then mixed briefly by vortex and subjected to 100,000 x g centrifugation for 45 min at 4 °C. All but approximately 50 µl of the sample supernatants were removed and 950 µl PBS, 0.5% Triton X-100 was added to each sample pellet. Each sample was then mixed briefly by vortex, and subjected to 100,000 x g centrifugation for 45 min at 4 °C. All but approximately 20 µl of the sample supernatants were removed. An equal volume of denaturation buffer (8 M urea, 10 mM Tris phosphate, pH 8.0, 0.5% Triton X-100) and 2 µl of 10X loading buffer (0.25% bromophenol blue, 50% glycerol) was added to each sample. An input control [ 32 P] poly(A) RNA sample was prepared at the same time and all samples were heated at 70°C for 10 min. Denatured samples were subjected to electrophoresis on a 1.2% 1x TBE agarose gel and then transferred to Biodyne B nylon membrane (Pierce) using 20x SSC transfer buffer and Whatmann 3MM chromatography paper (Fisher). After overnight transfer (~17 hrs) the membrane was exposed to Biomax MS film (Kodak) with a Hyperscreen intensifier screen (Amersham Biosciences). In order to calculate the stoichiometry of the interaction between nuclease-protected [ 32 P] poly(A) RNA and PrP C , we incubated [ 32 P] poly(A) RNA with PrP C at 37°C overnight. The sample was then subjected to centrifugation and the detergent-insoluble fraction was treated with benzonase. The sample was washed and centrifuged again to re-isolate the insoluble fraction. This fraction was denatured and subjected to agarose gel electrophoresis, transfer to a nylon membrane, and exposure to x-ray film.
Preparation of nuclease pre-treated PrP Sc
PrP
Sc derived from the fourth round of a seeded PMCA propagation reaction was diluted 1:10 into PBS, 2% Triton X-100. Brain-derived 237 PrP27-30 was prepared as previously described and also diluted 1:10 into PBS, 2% Triton X-100 (reference earlier paper for 27-30 preparation method JBC 2005). 20 µl of each PrP Sc dilution was combined with 180 µl of PBS, 2% Triton X-100, 4 µl of 100 mM MgCl 2 , and either 25 µl or 10 µl of 25U/µl benzonase was added to the PrP27-30 preparation and propagated PrP Sc samples, respectively. Identical, mock digested samples were prepared except PBS was added in the place of benzonase. Samples were incubated at 37°C for 30 min with shaking at 300 rpm. EDTA was added to each sample to a final concentration of 15 mM to inactivate the benzonase and samples were subjected to 100,000 x g centrifugation for 1 hr at 4°C. After centrifugation, all but approximately 15 µl of the sample supernatants were removed by aspiration. Sample pellets were resuspended in 185 µl PBS, 2% Triton X-100 for a final volume of 200 µl and then sonicated for 30 sec in a Misonix 3000-MPD programmable sonicator equipped with a microplate horn containing 350 ml water and set for output < 6.0. 10 µl of each PrP Sc preparation was used to seed 100 µl PMCA propagation reactions.
In situ PrP immunohistochemistry and acridine orange histochemistry
To study in situ co-localization of PrP and polyanions, scrapie infected (n = 3) and wild-type (n = 3) hamster brains were fixed in 10% formalin. Tissue sections were pretreated for antigen retrieval using established protocols (82, 83) . Briefly, tissue sections were deparaffinized in xylene followed by a 100%, 95%, 75%, and 50% ethanol series. After a water rinse, sections underwent: 1) Hydrated autoclaving at 121°C for 10 min; 2) microwave boiling in 10 mM citric acid buffer (pH 6.0) for 7 min; and 3) 88% formic acid for 7 min. Tissue sections stained with acridine orange were first washed with PBS and then stained with PBS (pH 6.0), 0.1% acridine orange (Molecular Probes, Invitrogen) for 15 minutes, differentiated in 0.1 M CaCl 2 , and washed with water. For PrP immunohistochemistry, tissue sections were blocked with 10% normal goat serum in PBS for 30 min at room temperature and incubated overnight at 4°C with a 1:50 dilution of 3F4 anti-PrP primary mouse IgG (Covance Research Products, Inc). Slides were then washed with PBS and incubated for 2 hrs at 37°C with a 1:200 dilution of green fluorescent Alexa Fluor 488-labeled secondary anti-mouse IgG (Molecular Probes, Invitrogen). Samples digested with RNase (Roche) were incubated for 1 hr at 37°C with 600 µg/ml of RNase in PBS and then washed with PBS. Tissue section slides treated with heparinase III (Sigma) were digested with 300 µl/slide of 1.6 units/ml heparinase in PBS, 4 mM CaCl 2 for 4.5 hours at room temperature and then washed with PBS. RNase and heparinase treatment proceeded PrP immunohistochemistry, followed by acridine orange staining. After processing, all tissue sections were air dried and mounted in Vectashield (Vector Labs) with 5 µg/ml DAPI (Sigma). Images were acquired with a Zeiss axiophot fluorescence microscope with 20x air or 100x oil lenses and Texas Red and FITC filter sets (Chroma). Images were captured with IPlab with manual control, equal and corresponding exposures, and adjusted and merged with ImageJ. Alexa Fluor 488 staining is pseudo-colored green and acridine orange staining is displayed as magenta to be red-green colorblind compatible.
Benzonase Activity Test
To test for benzonase activity in PMCA reactions containing oligo(dT), 50 ng of biotin-labeled oligo(dT) 100 was digested with benzonase under the same conditions as used in Figure 3 . Control samples containing biotin-labeled oligo(dT) 100 not treated with benzonase were also prepared. After treatment, all samples were transferred by slot blot to Pierce Biodyne B membrane pre-soaked in 6x SSC. The membrane was processed using the Pierce North2South chemiluminescent detection kit with a streptavidin-HRP secondary antibody. To test for benzonase activity in PMCA reactions containing RNA, 50 ng (~2K cpm) of synthetic [ 32 P] poly(A) RNA was digested with benzonase under the same conditions as used in Figure 4 and Figures S4A. A Sc . To prepare the substrate for these studies, we purified HaPrP C from normal hamster brain, and confirmed its purity by silver stain SDS-PAGE (Supplemental Data, Figure S1 ). We also performed a serial PMCA propagation reaction to confirm that this preparation of purified HaPrP C is a competent substrate for conversion to HaPrP Sc in autocatalytic reactions facilitated by several different polyanionic molecules, including poly(A) RNA, heparan sulfate, and polyglutamate, and some but not all branched, singlestranded poly(dT) DNA compounds (Supplemental Data, Figure S2 ).
In our first series of experiments, we examined the effect of a polyanion on the conformation of purified HaPrP C . One biochemical characteristic of PrP Sc is that it is detergent-insoluble under non-denaturing conditions (38) . To test whether a polyanion affects the detergent-solubility of HaPrP C , we carried out seeded and unseeded purified PMCA reactions (containing 0.35% Triton-X 100), in the presence or absence of synthetic poly(A) RNA ( Figure 1A) . Following one round of PMCA, each sample was subjected to ultracentrifugation, and the pellets were analyzed for the presence of detergent-insoluble HaPrP. As expected, detergent-insoluble HaPrP was formed in reactions seeded with HaPrP Sc ( Figure 1A , lanes 5-6), and HaPrP C alone did not become detergent-insoluble after PMCA ( Figure 1A, lanes 1-2) . However, detergentinsoluble HaPrP C was formed in unseeded reactions containing HaPrP C and poly(A) RNA without PrP Sc template ( Figure 1A,  lanes 3-4) . Only ~25% of the input HaPrP C was recovered in the detergent-insoluble pellet, though this amount is equivalent to the PrP recovered in the reactions seeded with HaPrP Sc ( Figure 1A ,
In order to confirm that poly(A) RNA molecules alter HaPrP conformation, and to test whether the resulting conformation might further resemble that of HaPrP Sc , we conducted an immunoprecipitation experiment using 89-112 mAb, a motifgrafted antibody which specifically recognizes the PrP Sc conformation ( Figure  1B) (39) . HaPrP Sc formed in seeded PMCA reactions was successfully immunoprecipitated by 89-112 mAb ( Figure  1B , lanes 5-6). Immunoprecipitation of unseeded reactions which lacked poly(A) RNA did not recover HaPrP C ( Figure 1B,  lanes 1-2) . In contrast, unseeded reactions containing HaPrP C and poly(A) RNA resulted in the formation of a PrP isoform that was immunoprecipitated by 89-112 mAb ( Figure 1B, lanes 3-4) . However, less PrP was immunoprecipitated from the unseeded reaction as compared to the seeded reaction ( Figure 1B, lanes 3-4 versus 5-6 ). We obtained qualitatively similar results with a different PrP Sc -specific antibody, mAb 15B3, although the immunoprecipitation experiment using this antibody was complicated by background affinity for purified HaPrP C ( Figure 1C ) (40) . These results indicate that, during PMCA, poly(A) RNA molecules can induce HaPrP C to adopt a conformation which is reactive against antibodies specific for the PrP Sc conformation. We also subjected parallel samples to digestion with 50 µg/ml proteinase K (PK) digestion for 1 hr at 37°C ( Figure 1D ). This analysis revealed that only the reaction seeded with PrP Sc resulted in the formation of protease-resistant HaPrP ( Figure 1D, lane 3) . PrP formed during reactions containing only HaPrP C , or HaPrP C plus poly(A) RNA, was not resistant to protease digestion even though HaPrP generated in the latter reaction was reactive against antibodies specific for the PrP Sc conformation ( Figure 1D, lanes 1-2) . These findings indicate that a subset of HaPrP molecules formed during unseeded PMCA reactions containing poly(A) RNA acquire some, but not all, properties of PrP Sc . Specifically, they are detergent insoluble and reactive with antibodies specific for the PrP Sc conformation, but they are proteasesensitive. In ongoing experiments, samples containing PrP C plus poly(A) RNA subjected to PMCA for 24 hr have not caused disease >200 days after intracerebral inoculation into Syrian hamsters (0/6).
Facilitation of purified prion propagation by synthetic oligonucleotides.
To determine the minimum polyanion length required to facilitate prion formation, we conducted serial PMCA propagation reactions with samples containing synthetic homopolymeric oligonucleotides of defined length (Figure 2A) . In our first experiment we tested the 100-mer polymers oligo(dT) 100 , oligo(dC) 100 , oligo(dA) 100 , and oligo(dG) 100 . We found that only the oligopyrimidines oligo(dT) 100 and oligo(dC) 100 facilitated prion propagation; oligo(dA) 100 and oligo(dG) 100 failed to support propagation (Figure 2A ). To determine more precisely the minimum oligonucleotide length required to facilitate serial PMCA propagation reactions, we carried out reactions containing synthetic oligo(dT) ranging in length from 10-90 bases ( Figure  2B ). In a control reaction lacking oligo(dT), HaPrP Sc was generated after the first round of PMCA but subsequent rounds failed to propagate this HaPrP Sc ( Figure 2B , bottom right panel). In contrast, oligo(dT) molecules between 40-90 bases in length consistently facilitated efficient propagation of HaPrP Sc ( Figure 2B , left and right panels). Oligo(dT) between 10-30 bases in length failed to facilitate propagation ( Figure 2B , right panel). The formation of HaPrP Sc in these latter samples during the first round of PMCA is attributable to residual nucleic acid molecules present in the HaPrP Sc template used to seed the reaction. However, upon serial dilution in subsequent PMCA reactions, the concentration of these seed-associated nucleic acids becomes too low to facilitate the conversion process. These data show that the minimum sized oligo(dT) required for efficient and reproducible in vitro prion propagation is ~40 bases in length.
Physical association between HaPrP and nucleic acid molecules in PMCAgenerated complexes. Our observation that poly(A) RNA molecules can induce a change in HaPrP C conformation led us to investigate whether polyanionic and HaPrP C molecules might form a physical complex during the course of PMCA reactions. For this purpose, we used a modified fluorescence microscopy technique originally developed to study the conformation of synthetic prion fibrils (41) . In a pilot experiment, we first identified a fluorescently labeled polyanionic molecule (i.e., oligo(dT) 100 labeled with fluorescein at the 5' end) that was able to facilitate HaPrP Sc propagation in a PMCA reaction (Figure 2A, bottom) . We then performed a series of experiments in which PMCA reactions were supplemented with this fluorescein-labeled oligo(dT) 100 instead of poly(A) RNA, and the association between HaPrP and fluorescein labeled oligo(dT) 100 was analyzed by dual-channel confocal microscopy ( Figure 3) . In an unseeded PMCA reaction, fluorescein-labeled oligo(dT) 100 molecules co-localized with insoluble HaPrP aggregates, indicating that polyanionic molecules can physically associate with HaPrP C molecules during PMCA (Figure 3, top panels) . Fluoresceinlabeled oligo(dT) 100 molecules also colocalized with the HaPrP aggregates in PMCA reactions seeded with HaPrP Sc (Figure 3, middle panels) . In contrast, when PMCA reactions were supplemented with fluorescein-labeled oligo(dA) 100 , a polyanion that does not support PrP Sc propagation (Figure 2A) , fluorescein signals were only detected in a subset of large aggregates (Supplemental Data, Figure S3 ).
Interestingly, when the products of PMCA reactions containing fluorescein-labeled oligo(dT) 100 molecules were treated with nuclease, the co-localized fluorescent signals were not abolished, indicating that fluorescein-labeled oligo(dT) 100 associated with HaPrP is largely protected from nuclease digestion (Figure 3 , bottom panels). Under this condition, however, we also observed some immunostained HaPrP aggregates that lacked fluorescein signal (white arrows). It is possible that the fluorescein-labeled oligo(dT) 100 molecules associated with these particular HaPrP molecules was not protected from nuclease digestion, or that it was partially protected but the digested portion of the oligo(dT) 100 included the 5' fluorescein group. We confirmed that benzonase is active under the conditions used in this assay by digesting dilutions of oligo(dT) 100 under identical digestion conditions (Supplemental Data, Figure S4A , lane 1 versus 2). Taken together, these data indicate that fluoresceinlabeled oligo(dT) 100 and HaPrP can form a physical complex during PMCA, which renders the nucleic acid largely inaccessible to the activity of a nuclease.
To test whether PrP C can physically interact with polyanionic molecules within a crude homogenate preparation (i.e. in the presence of competing factors), we performed binding assays using agarose-immobilized poly(A) RNA, heparan sulfate, and polyglutamate molecules. These experiments confirmed that both HaPrP C and MoPrP C bind to these polyanionic molecules in the context of a homogenate preparation (Supplemental Data, Figure S5 ).
Size-selective incorporation of poly(A)
RNA molecules into HaPrP-nucleic acid complexes during PMCA. To examine more closely the process by which polyanionic molecules are incorporated into HaPrP aggregates, we developed a nuclease protection assay using radiolabeled poly(A) RNA and HaPrP C molecules. To radiolabel poly(A) RNA, we employed a coupled enzymatic synthesis reaction which generates homopolymeric Figure S2B ). During synthesis, [ 32 P] AMP is randomly incorporated into poly(A) strands such that each base has an equal chance of being radiolabeled. This method produces [ 32 P] poly(A) RNA which is similar but not identical to the commercially available non-radioactive preparations that we routinely use in our PMCA propagation reactions. Specifically, the radiolabeled poly(A) RNA contains some poly(A) strands of greater length than those present in the commercially available poly(A) RNA (data not shown). While the commercial poly(A) RNA has a uniform size distribution, the radiolabeled poly(A) RNA we used in these experiments was predominantly of ~0.7 kb in length, though a widely heterogeneous mixture of poly(A) lengths were present in the preparation (Figure 4, lanes 7-8) .
We first studied the effect of PMCA incubation on the interaction between HaPrP C and radiolabeled poly(A) RNA in the absence of a HaPrP Sc template seed (Figure 4) . To address the mechanism by which poly(A) RNA renders HaPrP C detergent-insoluble during PMCA ( Figure  1A) , we began by characterizing the poly(A) RNA molecules associated with this polyanion-induced insoluble isoform of HaPrP. It should be noted that for the sake of consistency we used the same concentration of [ 32 (Figure 4, lane 6) . We then prepared identical reactions, but subjected them to PMCA incubation for 16 hr at 42°C (Figure 4, lanes 3-4) . Strikingly, in these samples the HaPrP-associated [ Densitometric analysis of the x-ray film using Photoshop software allowed us to quantify the amount of protected RNA by comparing it to a known quantity of the input [ 32 P] poly(A) RNA run as an internal control (data not shown). The average size of the protected [ 32 P] poly(A) RNA was estimated by comparing it to a radiolabeled RNA ladder on the same membrane. Using these values, we calculated the molar ratio of detergent-insoluble HaPrP to nucleaseprotected [ 32 P] poly(A) RNA to be ~160:1.
Using a serial propagation assay, we confirmed that the autocatalytic activity of HaPrP Sc molecules generated in vitro from HaPrP C and poly(A) RNA substrates is not abolished by nuclease digestion (Supplemental Data, Figure S6A) . Similarly, nuclease treatment did not destroy the autocatalytic activity of brain-derived HaPrP27-30 molecules (Supplemental Data, Figure S6B ). We confirmed that benzonase is active during treatment of the PrP Sc by digesting a dilution of [ 32 P] poly(A) RNA under identical digestion conditions (Supplemental Data, Figure S4B , lane 1 versus 3).
In situ co-localization of RNA with extracellular HaPrP aggregates in scrapie brain To determine whether polyanions colocalize with HaPrP aggregates in prion disease brains, we conducted neuropathological analysis of scrapieinfected hamsters. First we performed immunohistochemical staining for HaPrP and histochemical staining with acridine orange (AO), a monomeric cationic fluorescent dye ( Figure 5 ). HaPrP aggregates were readily detected in the extracellular space of sections from scrapie infected hamster brains ( Figure 5 , top left panel) but not in uninfected brains (Supplemental Data, Figure S7 ). AO staining co-localized with staining for HaPrP aggregates, which were typically ~5-10 µm in size ( Figure 5, top panels) . In some instances, we observed smaller HaPrP aggregates which did not stain with AO ( Figure 5 , white arrowheads). AO has been primarily used for detection of RNA, but it can also stain proteoglycans (42) (43) (44) (45) (46) . In order to determine the specificity of the AO staining in our samples, we treated brain sections with either RNase or heparinase prior to histochemical staining ( Figure 5 ). RNase treatment markedly reduced the AO staining associated with the HaPrP aggregates ( Figure 5, middle row) . Presumably, the antigen-retrieval pretreatment steps (hydrated autoclaving, boiling in citric acid, and incubation in formic acid) render the majority HaPrPassociated RNA molecules susceptible to nuclease digestion in these denatured tissue sections. In contrast, heparinase treatment did not significantly decrease the AO staining co-localized to the HaPrP aggregates ( Figure 5, bottom row) . Taken together, these findings indicate that RNA molecules are associated with HaPrP aggregates in the brains of scrapie-infected hamsters.
Discussion
In this manuscript, we report that during the in vitro formation of infectious hamster prions, synthetic nucleic acid molecules induce purified native HaPrP C to adopt a conformation similar to HaPrP Sc and, in doing so, become selectively incorporated into a complex which is resistant to nuclease digestion. In addition, we present evidence that RNA molecules co-localize with HaPrP aggregates in scrapie infected hamster brains.
Polyanion-induced intermediate conformation in the absence of PrP Sc
Folding intermediates have been implicated in the pathogenesis of many protein aggregation diseases (47). Therefore, it is important to identify the intermediate steps of PrP misfolding which lead to the formation of the infectious prion isoform, PrP Sc . One recent study identified a detergent-insoluble PrP conformer present in normal human brain, which is partially resistant to PK digestion (48), while another study showed that a misfolded PrP isoform was produced by cultured cells subjected to ER stress (49) . In vitro studies have demonstrated that under chemically destabilizing conditions, both native PrP C and bacterially expressed recombinant PrP (recPrP) can adopt intermediate conformations (50) (51) (52) (53) (54) (55) (56) (57) (58) . Similarly, nucleic acids have been shown to induce recPrP to adopt "-sheet-rich and amyloid conformations (16, 18, 58) . Although these PrP conformers may resemble misfolded precursors to PrP Sc , the systems used to generate these conformers have not been shown to produce infectious prions. In this study, using the PMCA system, we found that polyanions can induce native HaPrP C to become detergent-insoluble and reactive against PrP Sc -specific antibodies. However, this intermediate HaPrP isoform was not resistant to PK digestion, which indicates that additional conformational rearrangements are required to generate HaPrP Sc . Together, these findings support the hypothesis that polyanionic molecules can facilitate the misfolding of native HaPrP C during the formation of infectious hamster prions, even in the absence of template PrP Sc .
Polyanion incorporation into a nucleaseresistant HaPrP complex
Numerous studies have demonstrated that PrP can interact with nucleic acids in vitro (14) (15) (16) (17) (18) (19) (20) (21) (22) (23) (59) (60) (61) (62) (63) (64) (65) (66) . In previous reports, affinityselected, small highly structured synthetic (shs) RNA molecules were shown to interact in vitro with bacterially expressed recombinant human PrP (hrPrP) as well as brain-derived PrP C molecules (21, 61) . In addition, a subset of these shsRNAs formed nucleoprotein complexes with hrPrP which were partially resistant to RNase A and PK digestion (21) . Other shsRNA molecules which lacked affinity for PrP failed to form a nucleoprotein complex or confer PK resistance to PrP (21) . This indicates that the shsRNAs required specific structure and sequence, as well as affinity for PrP, for their functional interaction with PrP, an observation that differs from the findings presented in this report. In addition, none of these PrP-nucleic acid preparations have been shown to be infectious.
Previous studies by our group showed that polyanionic molecules facilitated the in vitro PMCA propagation of purified HaPrP Sc , as well as the de novo generation of infectious hamster prions in the absence of template PrP Sc (1) . Utilizing labeled homopolymeric nucleic acids, we found that PrP molecules can form a stable nucleoprotein complex in this system, which protects the nucleic acid components from nuclease digestion. Notably, [ 32 P] poly(A) RNA molecules only became nuclease-resistant when incubated with HaPrP overnight at 37 o C. This finding suggests that the formation of strong intermolecular interactions between polyanionic molecules and HaPrP molecules occurs in a time-dependent manner.
Currently, the molecular composition of native prions has not been fully determined. The most stringent interpretation of the "protein-only" hypothesis would be that the infectious unit is composed solely of the misfolded protein, PrP Sc (3 40 to be ~28 nm (67) . Using data from NMR structural studies of recPrP, we approximate the largest atomic dimension of a full-length HaPrP molecule to be ~7 nm and the smallest dimension to be ~3nm (68) . From these calculations, we estimate that 4-10 HaPrP molecules would be able to interact with a single oligo(dT) 40 Our finding that HaPrP selectively interacts with a subset of poly(A) RNA molecules during PMCA supports the hypothesis that prion strains could result from selective interaction with endogenous polyanions in vivo. This "co-factor selection" hypothesis differs from the "co-prion" hypothesis previously proposed by Weissmann (76) in that (i) co-factor molecules would be recruited from pre-existing cellular pools and therefore not need to replicate upon infection, and (ii) non-replicating polyanionic molecules such as proteoglycans could also serve as co-factors.
Prion-associated polyanions in situ
Previous studies have shown that cytoplasmic RNA molecules associate with neurofibrillary tangles and neuritic plaques in Alzheimer's disease brains and Pick bodies in Pick's disease brains (42, 77, 78) . Similarly, heparan sulfate proteoglycans were found to co-localize with PrP plaques in prion disease brains (79) . In this study, we used the cationic dye, acridine orange, to stain for polyanions associated with PrP aggregates in the brains of scrapie-infected hamsters. Interestingly, we found that acridine orange staining which co-localized with HaPrP aggregates was primarily due to the presence of RNA molecules. This finding is consistent with previous studies showing that nuclease-protected RNA molecules co-purify with prion infectivity (80, 81) , and that endogenous RNA molecules can facilitate the conversion and propagation of hamster prions in vitro (1) . It is possible that a diversity of polyanionic molecules, including RNA and heparan sulfate proteoglycans, protein chaperones, and negatively charged lipid membranes may facilitate the process of conformational conversion during prion formation in vivo, and possibly even promote the differential formation of prion strains. However, further work is needed to identify comprehensively the specific polyanionic molecules associated with PrP aggregates in situ, and to determine fully their roles in the pathogenesis of prion disease. Sc template used to seed the reactions was generated in a serial propagation reaction containing synthetic oligo(dT) 100 . A sample containing HaPrP C not subjected to proteinase K digestion is shown in the first lane as a reference for comparison of electrophoretic mobility (PrP C -PK). All the other samples shown on the blots were subjected to limited proteolysis with 50 µg/ml proteinase K (+PK). " = Negative control sample containing no polyanion molecules. Sc . All samples were subjected to one round of PMCA and prepared for analysis as described in "Methods". The sample pellet from a seeded reaction was digested with 50 U of benzonase before analysis (Seeded + Nuclease). All samples were analyzed by fluorescence microscopy as described under "Methods" to visualize HaPrP and oligo(dT). HaPrP aggregates were immunostained with an anti-PrP mAb and Alexa Fluor 568-labeled secondary antibody, and are shown in magenta (PrP). The oligo(dT) 100 molecules were visualized by the fluorescein label and are shown in green (Fluorescein). Co-localized HaPrP and fluorescein-labeled oligo(dT) 100 were identified by overlaying both images (Merge). Scale bar = 200 µm. . All samples contained 20 µg/ml (~50K cpm) [ 32 P] poly(A) RNA. Samples were subjected to either one round of PMCA (lanes 1-4) or no PMCA (lanes 5-6) and prepared for analysis as described in "Methods". Pellets from each sample were treated with 50U of benzonase (lanes 2, 4, 6) or without benzonase (lanes 1, 3, 5 ). 100 pg (1/60,000 th ) of the total input [ 32 P] poly(A) RNA (lane 7) was included on the same blot as a reference for poly(A) RNA length though this sample's position on the blot was moved as indicated by the space between lanes. The same [ 32 P] poly(A)
RNA preparation was also subjected to a separate analysis in order to obtain a darker exposure (lane 8). 
